NCT00002021View on ClinicalTrials.gov

An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies

NACompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Herpes SimplexHIV Infections

Interventions

DRUG

Foscarnet sodium

Trial Locations (2)

90095

UCLA CARE Ctr, Los Angeles

91105

Huntington Memorial Hosp, Pasadena

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Astra USA

INDUSTRY

NCT00002021 - An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies | Biotech Hunter | Biotech Hunter